QQQ   420.10 (+1.31%)
AAPL   166.69 (+1.02%)
MSFT   401.73 (+0.65%)
META   485.37 (+0.89%)
GOOGL   156.95 (+1.86%)
AMZN   177.57 (+1.68%)
TSLA   142.27 (-3.25%)
NVDA   799.14 (+4.87%)
AMD   149.22 (+1.76%)
NIO   4.02 (+5.79%)
BABA   70.82 (+2.53%)
T   16.35 (-0.97%)
F   12.87 (+6.01%)
MU   109.79 (+2.83%)
GE   150.78 (+1.84%)
CGC   7.90 (-0.38%)
DIS   112.80 (+0.17%)
AMC   3.40 (+7.59%)
PFE   26.41 (+1.58%)
PYPL   63.29 (+1.57%)
XOM   121.16 (+1.07%)
QQQ   420.10 (+1.31%)
AAPL   166.69 (+1.02%)
MSFT   401.73 (+0.65%)
META   485.37 (+0.89%)
GOOGL   156.95 (+1.86%)
AMZN   177.57 (+1.68%)
TSLA   142.27 (-3.25%)
NVDA   799.14 (+4.87%)
AMD   149.22 (+1.76%)
NIO   4.02 (+5.79%)
BABA   70.82 (+2.53%)
T   16.35 (-0.97%)
F   12.87 (+6.01%)
MU   109.79 (+2.83%)
GE   150.78 (+1.84%)
CGC   7.90 (-0.38%)
DIS   112.80 (+0.17%)
AMC   3.40 (+7.59%)
PFE   26.41 (+1.58%)
PYPL   63.29 (+1.57%)
XOM   121.16 (+1.07%)
QQQ   420.10 (+1.31%)
AAPL   166.69 (+1.02%)
MSFT   401.73 (+0.65%)
META   485.37 (+0.89%)
GOOGL   156.95 (+1.86%)
AMZN   177.57 (+1.68%)
TSLA   142.27 (-3.25%)
NVDA   799.14 (+4.87%)
AMD   149.22 (+1.76%)
NIO   4.02 (+5.79%)
BABA   70.82 (+2.53%)
T   16.35 (-0.97%)
F   12.87 (+6.01%)
MU   109.79 (+2.83%)
GE   150.78 (+1.84%)
CGC   7.90 (-0.38%)
DIS   112.80 (+0.17%)
AMC   3.40 (+7.59%)
PFE   26.41 (+1.58%)
PYPL   63.29 (+1.57%)
XOM   121.16 (+1.07%)
QQQ   420.10 (+1.31%)
AAPL   166.69 (+1.02%)
MSFT   401.73 (+0.65%)
META   485.37 (+0.89%)
GOOGL   156.95 (+1.86%)
AMZN   177.57 (+1.68%)
TSLA   142.27 (-3.25%)
NVDA   799.14 (+4.87%)
AMD   149.22 (+1.76%)
NIO   4.02 (+5.79%)
BABA   70.82 (+2.53%)
T   16.35 (-0.97%)
F   12.87 (+6.01%)
MU   109.79 (+2.83%)
GE   150.78 (+1.84%)
CGC   7.90 (-0.38%)
DIS   112.80 (+0.17%)
AMC   3.40 (+7.59%)
PFE   26.41 (+1.58%)
PYPL   63.29 (+1.57%)
XOM   121.16 (+1.07%)
NASDAQ:KA

Kineta (KA) Stock Price, News & Analysis

$0.63
+0.10 (+19.07%)
(As of 02:58 PM ET)
Today's Range
$0.51
$0.74
50-Day Range
$0.34
$2.83
52-Week Range
$0.33
$5.39
Volume
762,957 shs
Average Volume
298,780 shs
Market Capitalization
$6.88 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$8.00

Kineta MarketRank™ Stock Analysis

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
1,169.6% Upside
$8.00 Price Target
Short Interest
Healthy
0.82% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($1.41) to ($1.35) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.84 out of 5 stars

KA stock logo

About Kineta Stock (NASDAQ:KA)

Kineta, Inc. is a clinical-stage biotechnology company with a focus on developing immunotherapies that transform patients' lives. It focuses on developing potentially differentiated immunotherapies that address the challenges with current cancer therapy. The company's immuno-oncology pipeline includes KVA12123, a VISTA blocking immunotherapy in development as a twice weekly monoclonal antibody (mAb) infusion drug. KVA12123 is being evaluated in a Phase 1/2 clinical trial as a monotherapy and in combination with pembrolizumab in patients with advanced solid tumors, including non-small cell lung, ovarian, head and neck, renal cell, and colorectal cancers. It is also developing anti-CD27 agonist mAb immunotherapy, which is in preclinical development for advanced solid tumors, such as renal cell carcinoma, ovarian, and colorectal cancers. The company has collaboration and license agreements with MSD International Business GmbH, Genentech, Inc., FAIR Therapeutics B.V., and GigaGen, Inc. Kineta, Inc. was founded in 2007 and is headquartered in Seattle, Washington.

KA Stock Price History

KA Stock News Headlines

The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
The A.I. story nobody is telling you (Read ASAP)
There's been a lot of buzz surrounding A.I. over the past year... Most of it is just hype and speculation. But there's one recent A.I. development you NEED to hear about...
Kineta to Present at Upcoming Investor Conferences
Kineta to Present at Upcoming Investor Conferences
KA: Phase I/II Update
KA: Third Quarter Results - MSN
KA: Third Quarter Results
See More Headlines
Receive KA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Kineta and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
3/21/2024
Today
4/22/2024
Next Earnings (Estimated)
5/09/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Fax
N/A
Employees
11
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$8.00
High Stock Price Target
$8.00
Low Stock Price Target
$8.00
Potential Upside/Downside
+1,416.3%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-14,100,000.00
Pretax Margin
-258.65%

Debt

Sales & Book Value

Annual Sales
$5.44 million
Book Value
$0.29 per share

Miscellaneous

Free Float
7,695,000
Market Cap
$5.78 million
Optionable
Not Optionable
Beta
0.52
7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors Cover

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

KA Stock Analysis - Frequently Asked Questions

Should I buy or sell Kineta stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Kineta in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" KA shares.
View KA analyst ratings
or view top-rated stocks.

What is Kineta's stock price target for 2024?

1 Wall Street analysts have issued 1 year price targets for Kineta's shares. Their KA share price targets range from $8.00 to $8.00. On average, they anticipate the company's share price to reach $8.00 in the next twelve months. This suggests a possible upside of 1,169.6% from the stock's current price.
View analysts price targets for KA
or view top-rated stocks among Wall Street analysts.

How have KA shares performed in 2024?

Kineta's stock was trading at $3.63 at the beginning of the year. Since then, KA shares have decreased by 82.6% and is now trading at $0.6301.
View the best growth stocks for 2024 here
.

Are investors shorting Kineta?

Kineta saw a decrease in short interest in March. As of March 31st, there was short interest totaling 61,800 shares, a decrease of 17.9% from the March 15th total of 75,300 shares. Based on an average daily volume of 205,100 shares, the short-interest ratio is currently 0.3 days. Approximately 0.8% of the shares of the company are short sold.
View Kineta's Short Interest
.

When is Kineta's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our KA earnings forecast
.

How were Kineta's earnings last quarter?

Kineta, Inc. (NASDAQ:KA) released its quarterly earnings data on Thursday, March, 21st. The company reported ($0.19) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.10.

How do I buy shares of Kineta?

Shares of KA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:KA) was last updated on 4/22/2024 by MarketBeat.com Staff

From Our Partners